Paul Tudor Jones Minerva Surgical Inc Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.82 - $17.0 $279 - $5,797
-341 Reduced 1.89%
17,738 $14,000
Q2 2022

Aug 15, 2022
SELL
$1.75 - $4.5 $2,803 - $7,209
-1,602 Reduced 8.14%
18,079 $42,000
Q1 2022

May 16, 2022
SELL
$4.26 - $5.82 $11,493 - $15,702
-2,698 Reduced 12.06%
19,681 $89,000
Q4 2021

Feb 14, 2022
BUY
$4.53 - $9.78 $101,376 - $218,866
22,379 New
22,379 $115,000

About MINERVA SURGICAL INC

UTRS Quotes by TradingView
  • Ticker UTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 28,860,000
  • Description
  • Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation de...
More about UTRS
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email